Rapidtest.AI
AI reads rapid tests via smartphone to deliver consistent, digital diagnostic results.
Company Overview
Snapshot
Founded in March 2025, Rapidtest.AI operates with 1–10 employees. The company is currently in its Pre-Funding stage, focusing on developing its core technology.
Business overview
Rapidtest.AI is developing an AI-powered computer-vision engine designed to convert standard lateral-flow rapid tests into digital, structured, and shareable diagnostic results. The company aims to reduce subjective interpretation of test results and enable instant digitization for downstream clinical workflows. Its platform is being built for integration with healthcare systems such as EHRs, telehealth providers, and pharmaceutical partners, emphasizing a privacy- and compliance-oriented architecture with patented technology. Rapidtest.AI operates within the Digital Medical Diagnostics sector, a sub-segment of Digital Healthcare and the broader Health Tech & Life Sciences industry.
Company Intelligence Q&A
- What is Rapidtest.AI's primary focus?
- Rapidtest.AI focuses on developing an AI-powered computer-vision engine that converts standard lateral-flow rapid tests into digital, structured, and shareable diagnostic results.
- When was Rapidtest.AI founded?
- Rapidtest.AI was founded in March 2025.
- What problem does Rapidtest.AI aim to solve?
- Rapidtest.AI aims to reduce subjective interpretation of rapid test results and enable instant digitization for downstream clinical workflows.
- What is the current stage of Rapidtest.AI's product development?
- Rapidtest.AI's product is currently in the Beta stage, indicating active development and testing of its AI-powered computer-vision engine for digital diagnostic results.
- Which industries does Rapidtest.AI target?
- Rapidtest.AI targets the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Medical Diagnostics.